Atlas Trials

A Repeated Dose Study of the Metabolism and Action Evaluation of OROS Hydromorphone HCI (Slow Release) Tablets in Patients With Chronic Pain

Clinical trial NCT00410878 · COMPLETED

Trial details

NCT number
NCT00410878
Sponsor
Alza Corporation, DE, USA
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
PainAnalgesics, Opioid
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.